Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia announces financial results for 2021 – 2022 to be a transformative year – Sustainable profitability expected in 2025
08.02.2022 - Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – February 8, 2022 Idorsia Ltd (SIX: IDIA) today announced its financial results for 2021. Business highlights QUVIVIQ (daridorexant) 25 mg and 50 mg approved by the US Food and .
Investegate announcements from Idorsia Pharmaceuticals Ltd, Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada
Idorsia Pharmaceuticals Ltd: Idorsia expands its commercialization partnership with Syneos Health for daridorexant in Europe and Canada finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.